Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P₂RX₇ purinoceptor antagonism

Research output: Contribution to journal › Article › peer-review

154 Downloads (Pure)

Data availability statement for 'Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism'.
Al-Khalidi, R. (Creator), Panicucci, C. (Creator), Cox, P. (Creator), Chira, N. (Creator), Róg, J. (Creator), Young, C. (Creator), Lloyd, R. (Creator), Ambati, K. (Creator), Ambati, J. (Creator), Zablocki, K. (Creator), Gazzerro, E. (Creator), Arkle, S. (Creator), Bruno, C. (Creator) & Gorecki, D. (Creator), Springer Nature, 26 Mar 2018
DOI: 10.1186/s40478-018-0530-4, https://actaneurocomms.biomedcentral.com/articles/10.1186/s40478-018-0530-4
Dataset

Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism